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Maternal thyroid hormones (MTH) have a key role during fetal development.
MTH deficiency during gestation can cause cognitive alterations in the
offspring. Two main MTH deficiencies are described: hypothyroidism (low
T4, high TSH) and hypothyroxinemia (low T4, normal TSH and T3). The
molecular role of MTH has not been yet fully elucidated. THs exert a nuclear
genomic effect by inducing the expression of target genes. T3 can bind to
thyroid hormone receptors (TRs), promoting their translocation to the nucleus
and modifying the expression of TH-responsive genes. Here, we analize in
vivo and in vitro the expression of TR, TH transporters and key proteins
associated to the molecular mechanism of TH, in brain cortex and hippocam-
pus of adult offspring gestated under MTH deficiency. At functional level,
long tem potentiation (LTP) was evaluated in vivo and chemical LTP
(chLTP) was evaluated in vitro. An alteration into TR and transporters
expression levels was observed in cortex and hippocampus together with
an alteration of both LTP and chLTP. This work contributes to elucidate
the molecular mechanism associated to the MTH role in the progeny CNS
development.
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P2X receptors are commonly known as plasma membrane cation channels
involved in a wide variety of cell functions. Recently, it was shown that in
addition to plasma membrane expression, mammalian P2X4 was also local-
ized intracellularly in lysosomes. However, it was not clear whether the lyso-
somal P2X4 receptors function as channels and how they are regulated. In this
study, we show that both P2X4 and its natural ligand, ATP, are enriched in
lysosomes of mammalian cells. By directly recording membrane currents
from enlarged lysosomal vacuoles, we demonstrate that lysosomal P2X4 pro-
teins form channels activated by ATP from the luminal side in a pH dependent
manner. While the acidic pH at the luminal side inhibits P2X4 activity,
increasing the luminal pH in the presence of ATP causes P2X4 activation.
We further show that SLC17A9 (solute carrier family 17 member 9), also
known as VNUT (vesicular nucleotide transporter), functions as an ATP trans-
porter in lysosomes where it transports ATP into lysosomes to activate P2X4
channels. Taken together, our data suggest that P2X4 acts as a lysosomal
channel regulated by a number of factors including luminal ATP, luminal
pH, and membrane SLC17A9. Such regulation may be important for lysosome
physiology.
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We used site-directed mutagenesis and labeling of the type 1 ryanodine re-
ceptor (RyR1) recombinantly expressed in HEK-293T cells to identify
RyR1 residues that interact with FKBP12, a constitutively-bound protein
that promotes the closed state of the RyR1 calcium channel. While the
location of bound FKBP on the RyR1 cryo electron microscopic (EM)
map is known, the RyR1 sequence elements forming the FKBP binding
site are poorly understood. Previously, we have shown that a His10 tag in-
serted at RyR1 position 620, adjacent to the N-terminal ‘‘ABC’’ domains,
abolished FKBP binding. Here, we used structural modeling to predict loop
regions in downstream domains, and then used these loops for His10 inser-
tion sites. Fluorescent FKBP (F-FKBP) binding was then assessed in func-
tional, full-length RyR1 containing these His10 tags. We determined thatinsertion of His10 tags in specific loops could completely abolish F-
FKBP binding, even though RyR1 calcium release activity was unaffected.
Scrambling the amino acid sequence of the loops identified using His10
tags also eliminated F-FKBP binding. The effects of disrupting these loops
on F-FKBP binding were far more pronounced compared to previously es-
tablished FKBP binding motifs, such as the VP dipeptide at RyR1 position
2461 and the PKA phosphorylation site at position 2843 within the PKA/
CaMKII phosphorylation loop of RyR1. Thus, our results identify novel
major FKBP binding determinants in RyR1. Supported by NIH and
Canadian grants R01AR059126 (to JDF) R01HL092097 (to RLC), and
CIHR 259009 (to FVP).
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Aims: Cardiac aging is one of the main causes of heart dysfunction and other
cardiac diseases. FK506 binding protein 12.6 (FKBP12.6) modulates Ca2þ
release from the sarcoplasmic reticulum in cardiomyocytes. Previous studies
implied that genetic deletion of FKBP12.6 leads to cardiac aging related
phenotypes. However, the role and mechanism of FKBP12.6 in the process
of cardiac aging remain unclear.
Methods and Results: To assess whether FKBP12.6 is involved in cardiac aging
and age-related heart dysfunction, FKBP12.6 knockout (KO) and control litter-
mate mice were used throughout the study. We found a significant association
between deletion of FKBP12.6 and cardiac aging. Indeed, aged FKBP12.6 KO
mice exhibited markedly impaired cardiac function compared to wild-type.
Strikingly, FKBP12.6 deletion resulted also in increased levels of cell cycle in-
hibitors p16 and p19, augmented cardiac fibrosis, cell death, and shorter telo-
meres. Finally, we demonstrated that FKBP12.6 deletion enhanced insulin
signaling in the hearts, resulting in AKT phosphorylation, augmented mTOR
activity, and impaired autophagy.
Conclusions: Taken together, these results identify that genetic deletion of
FKBP12.6 promotes cardiac aging and indicate that the activation of the
AKT/mTOR pathway plays a mechanistic role in the process.
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Weakened atrial contractility is a common comorbidity in heart failure (HF)
that increases severity of HF symptoms. The role of intracellular calcium
(Ca) handling remodeling in pathogenesis of ventricular contractile failure
has been well established. However, the relationship between Ca signaling
and atrial dysfunction in HF is not well recognized. We studied intracel-
lular Ca handling in atrial myocytes isolated from control dogs and dogs
with tachypacing-induced chronic HF. Ca transients and cellular shortening
were reduced, while sarcoplasmic reticulum (SR) Ca content was increased
in field-stimulated myocytes from HF compared to controls. Both control
and HF myocytes have scarce t-tubule density, and Ca transients originated
predominantly at the periphery of myocytes in both groups. Diminished Ca
transients in HF myocytes were associated with decreased peripheral Ca
release and impaired propagation of Ca signal from sarcolemma to the cen-
tral areas of the myocyte. Peak density of the L-type Ca currents and gain
of excitation-contraction coupling were reduced in voltage-clamped HF my-
ocytes compared to control myocytes. Analysis of decay of caffeine- and
electrically-induced Ca transients suggests reduced Na/Ca exchanger activ-
ity and increased SR Ca ATPase (SERCA) activity in HF myocytes.
SERCA inhibition with cyclopiazonic acid did not improve centripetal
propagation of Ca signal in HF myocytes. In contrast, L-type Ca channel
agonist BayK 8644 increased peripheral Ca release, improved centripetal
Ca wave propagation and restored shortening of HF myocytes to control
levels.
We conclude that defective activation and impaired propagation of the SR Ca
release in atrial myocytes contribute to compromised atrial contractility in
chronic HF. Our results suggest L-type Ca channels as a therapeutic target
for treatment of atrial contractile dysfunction in HF.
